Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
-3.28%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$14.6B
AUM Growth
+$1.44B
(+11%)
Cap. Flow
+$1.76B
Cap. Flow
% of AUM
12.06%
Top 10 Holdings %
Top 10 Hldgs %
13.07%
Holding
649
New
145
Increased
154
Reduced
121
Closed
154
Top Buys
| 1 |
AerCap
AER
|
+$212M |
| 2 |
Adobe
ADBE
|
+$160M |
| 3 |
Analog Devices
ADI
|
+$154M |
| 4 |
Salesforce
CRM
|
+$109M |
| 5 |
Paycom
PAYC
|
+$109M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$189M |
| 2 |
NVIDIA
NVDA
|
+$164M |
| 3 |
Dollar Tree
DLTR
|
+$148M |
| 4 |
Vertiv
VRT
|
+$144M |
| 5 |
Dell
DELL
|
+$122M |
Sector Composition
| 1 | Technology | 22.73% |
| 2 | Consumer Discretionary | 16.17% |
| 3 | Industrials | 14.74% |
| 4 | Healthcare | 13.71% |
| 5 | Financials | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
LINKBANCORP
LNKB
$270M
| $1.14M | 0.01% |
166,357
-5,253
| -3% | -$36K |
|
402
SELLAS Life Sciences
SLS
$200M
| $1.05M | 0.01% |
640,011
-609,989
| -49% | -$1M |
|
403
Otis Worldwide
OTIS
$34.3B
| $1.04M | 0.01% |
12,995
-574,799
| -98% | -$46.2M |
|
|
EVLO
404
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $1.04M | 0.01% |
+265,103
| New | +$1.04M |
|
|
FNA
405
DELISTED
Paragon 28, Inc.
FNA
| $1.03M | 0.01% |
82,192
+25,000
| +44% | +$314K |
|
406
Elutia
ELUT
$79.7M
| $942K | 0.01% |
663,244
+448,901
| +209% | +$638K |
|
407
Clene
CLNN
$66.2M
| $922K | 0.01% |
92,916
-5,741
| -6% | -$56.9K |
|
408
Fulcrum Therapeutics
FULC
$393M
| $898K | 0.01% |
202,148
| – | – |
|
409
Ametek
AME
$43.6B
| $874K | 0.01% |
+5,914
| New | +$874K |
|
410
Werewolf Therapeutics
HOWL
$60.8M
| $851K | 0.01% |
397,808
| – | – |
|
411
Better Home & Finance Holding
BETR
$383M
| $838K | 0.01% |
+35,000
| New | +$838K |
|
412
AN2 Therapeutics
ANTX
$32.5M
| $804K | 0.01% |
50,000
-48,426
| -49% | -$779K |
|
413
Nektar Therapeutics
NKTR
$843M
| $793K | 0.01% |
+88,781
| New | +$793K |
|
414
MDxHealth
MDXH
$176M
| $783K | 0.01% |
279,555
| – | – |
|
415
Hyperfine
HYPR
$93.5M
| $769K | 0.01% |
375,000
| – | – |
|
|
SCTL
416
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $749K | 0.01% |
1,597,931
| – | – |
|
|
AXDX
417
DELISTED
Accelerate Diagnostics
AXDX
| $712K | ﹤0.01% |
123,898
-1
| -0% | -$6 |
|
|
SNCE
418
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $707K | ﹤0.01% |
88,319
| – | – |
|
419
HilleVax
HLVX
$105M
| $706K | ﹤0.01% |
+52,500
| New | +$706K |
|
|
MDVL
420
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $698K | ﹤0.01% |
116,300
-4,001
| -3% | -$24K |
|
421
Owens Corning
OC
$13B
| $686K | ﹤0.01% |
+5,027
| New | +$686K |
|
422
Caribou Biosciences
CRBU
$169M
| $598K | ﹤0.01% |
+125,000
| New | +$598K |
|
|
NMRD
423
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
| $580K | ﹤0.01% |
1,842,565
-640,706
| -26% | -$202K |
|
424
Lexicon Pharmaceuticals
LXRX
$392M
| $555K | ﹤0.01% |
509,484
-1,232,868
| -71% | -$1.34M |
|
425
CorMedix
CRMD
$952M
| $555K | ﹤0.01% |
150,000
-850,000
| -85% | -$3.15M |
|